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Doxycycline resistance in Plasmodium falciparum linked to single nucleotide polymorphisms in
the Plasmodium falciparum apicoplast small subunit ribosomal RNA (pfSSrRNA) gene
Plasmodium falciparum, a protozoan parasite known as malaria, widely impacts human
health; thus antimalarial drug investigations are critical. Doxycycline is a commonly used
antimalarial prophylactic, but its mechanism of action is unclear. In prokaryotes, doxycycline
works as an antibacterial by disrupting protein translation via the small subunit ribosome.
Interestingly, P. falciparum has a small subunit ribosome of prokaryotic origins in the apicoplast,
a plastid-like organelle. Therefore, we hypothesized that doxycycline works in P. falciparum by
inhibiting protein synthesis via the small subunit ribosomal RNA and that mutations in the gene
encoding the P. falciparum apicoplast small subunit ribosomal RNA (pfSSrRNA) are associated
with doxycycline resistance. We generated nine doxycycline-resistant parasite lines with
continuous incremental drug pressure over approximately twelve months. Resistant lines had
doxycycline IC50 values of ~2.4 μM while the drug-free control had an IC50 of 587 nM, resulting
in a ~4 fold decrease in doxycycline susceptibility as measured by 96-hour growth inhibition
assays. Sequencing of the pfssrRNA gene in a resistant line revealed a g439a single nucleotide
polymorphism (SNP). We suspect this mutation reduces parasite susceptibility to doxycycline by
altering the molecular structure of the apicoplast SSrRNA, so that doxycycline can no longer
inhibit protein synthesis. Future studies involve cloning the resistant lines, sequencing pfssrRNA
for all resistant lines, and characterizing the drug phenotypes of the resistant lines to doxycycline
and a panel of standard antimalarial drugs. Understanding how doxycycline works will help
health care professionals better combat doxycycline resistance in the field.

